Published in Health Insurance Week, December 31st, 2006
Study 1: Molecular medicine, the Medicare drug benefit, and the need for cost control are the focus of a report published in a recent issue of the Journal of the American Geriatrics Society.
According to a report from the United States, "The implementation of Medicare Part D, although successful in improving access to prescription drugs for millions of beneficiaries, will lead to a marked escalation in the cost of the Medicare program. An important component of the rise in costs will be specialty pharmaceuticals, including a group of drugs that are self-administered...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.